Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
What Happens To Index Funds During Recession: Historically, broad market indices may drop, but diversified funds can recover faster as economies stabilize.
20,157 articlesA bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Jim Cramer declares Broadcom undervalued after a solid earnings quarter with AI revenue accelerating; investors weigh...
U.S. Customs announced a 45-day, no-lawsuits refund program for tariffs, aiming to speed refunds to importers and red...
Coca-Cola outpaced PepsiCo over the past decade on total return, driven by an asset-light strategy and Zero Sugar mom...
A new leadership playbook is on the table at Target. This article breaks down five actionable takeaways from the late...
The Justice Department unveiled a tentative settlement with Ticketmaster and Live Nation that would impose a civil pe...
C3.AI has faced a rough run, leaving investors wondering if a comeback is possible. This article breaks down the fact...
Stocks drift lower on March 10, 2026 as oil prices slide, muting tech gains. This stock market live march update expl...
Peter Thiel's hedge fund sold Nvidia shares and shifted into Microsoft and Apple, signaling a strategic pivot in AI b...
XRP rose about 4% amid cautious optimism in risk assets, yet on-chain data show exchange activity collapsing to histo...
The Agent Impact Network has reached 385,000 agents, adding about 2,000 new members each month and expanding its inve...
President Trump announces plans for the first new U.S. oil refinery in nearly five decades, backed by Reliance Indust...